GLP1R inhibits the progression of endometrial carcinoma through activation of cAMP/PKA pathway

BACKGROUND: This study strived to explore the role and mechanism of glucagon‐like peptide‐1 receptor (GLP1R) in endometrial carcinoma (EC). METHODS: In detail, after transfection of GLP1R overexpression vector and small interfering RNA targeting PKA, the mRNA expressions of GLP1R and PKA in EC cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wu, Gu, Yanpin, Liu, Songjun, Ruan, Fan, Lv, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551121/
https://www.ncbi.nlm.nih.gov/pubmed/35989517
http://dx.doi.org/10.1002/jcla.24604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551121/
https://www.ncbi.nlm.nih.gov/pubmed/35989517
http://dx.doi.org/10.1002/jcla.24604

Ejemplares similares